EcoDrugPlus

Bruton Tyrosine Kinase

Ensembl ID : ENSTTRG00000012776
Gene Symbol: BTK
1 Cross references
207 Possible Orthologues:

C-C Motif Chemokine Receptor 2

Ensembl ID : ENSTTRG00000017293
Gene Symbol: CCR2
1 Cross references
286 Possible Orthologues:

C-C Motif Chemokine Receptor 4

Ensembl ID : ENSTTRG00000016781
Gene Symbol: CCR4
1 Cross references
254 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSTTRG00000009602
Gene Symbol: CCR9
1 Cross references
262 Possible Orthologues:

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSTTRG00000017069
Gene Symbol: CFTR
1 Cross references
216 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSTTRG00000003178
Gene Symbol: DNMT1
1 Cross references
206 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSTTRG00000004580
Gene Symbol: TOP1
1 Cross references
270 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSTTRG00000016905
Gene Symbol: TOP2A
1 Cross references
209 Possible Orthologues:

Dna Topoisomerase Ii Beta

Ensembl ID : ENSTTRG00000010918
Gene Symbol: TOP2B
3 Cross references
208 Possible Orthologues:

Emap Like 4

Ensembl ID : ENSTTRG00000012677
Gene Symbol: EML4
1 Cross references
209 Possible Orthologues:

Eph Receptor A2

Ensembl ID : ENSTTRG00000017387
Gene Symbol: EPHA2
1 Cross references
124 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSTTRG00000000704
Gene Symbol: EPHA3
3 Cross references
215 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).